+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation

American Journal of Pathology 184(5): 1577-1592
Preferential lymphatic growth in bronchus-associated lymphoid tissue in sustained lung inflammation
Lymphatics proliferate, become enlarged, or regress in multiple inflammatory lung diseases in humans. Lymphatic growth and remodeling is known to occur in the mouse trachea in sustained inflammation, but whether intrapulmonary lymphatics exhibit similar plasticity is unknown. We examined the time course, distribution, and dependence on vascular endothelial growth factor receptor (VEGFR)-2/VEGFR-3 signaling of lung lymphatics in sustained inflammation. Lymphatics in mouse lungs were examined under baseline conditions and 3 to 28 days after Mycoplasma pulmonis infection, using prospero heomeobox 1-enhanced green fluorescence protein and VEGFR-3 as markers. Sprouting lymphangiogenesis was evident at 7 days. Lymphatic growth was restricted to regions of bronchus-associated lymphoid tissue (BALT), where VEGF-C-producing cells were scattered in T-cell zones. Expansion of lung lymphatics after infection was reduced 68% by blocking VEGFR-2, 83% by blocking VEGFR-3, and 99% by blocking both receptors. Inhibition of VEGFR-2/VEGFR-3 did not prevent the formation of BALT. Treatment of established infection with oxytetracycline caused BALT, but not the lymphatics, to regress. We conclude that robust lymphangiogenesis occurs in mouse lungs after M. pulmonis infection through a mechanism involving signaling of both VEGFR-2 and VEGFR-3. Expansion of the lymphatic network is restricted to regions of BALT, but lymphatics do not regress when BALT regresses after antibiotic treatment. The lung lymphatic network can thus expand in sustained inflammation, but the expansion is not as reversible as the accompanying inflammation.

(PDF same-day service: $19.90)

Accession: 055116948

PMID: 24631179

DOI: 10.1016/j.ajpath.2014.01.021

Related references

Inducible Bronchus-Associated Lymphoid Tissue: Taming Inflammation in the Lung. Frontiers in Immunology 7: 258-258, 2016

Development of bronchus-associated lymphoid tissue hyperplasia following lipopolysaccharide-induced lung inflammation in rats. Experimental Lung Research 35(3): 186-197, 2009

T cell localization in gut associated lymphoid tissue bronchus associated lymphoid tissue and lung parenchyma in rabbit models of hypersensitivity pneumonitis. Federation Proceedings 45(4): 995, 1986

Subpopulations of non-lymphoid cells in bronchus associated lymphoid tissue and lung of the mouse. Advances in Experimental Medicine and Biology 237: 607-613, 1988

Preferential uptake of soluble antigen by respiratory tract epithelium overlying bronchus-associated lymphoid tissue in the rat. Advances in Experimental Medicine and Biology 149: 499-505, 1982

Effect of glucocorticoid on lung tissue and bronchus-associated lymphoid tissue of experimental granulomatous lung. Kekkaku 64(6): 387-399, 1989

Lymphocyte subpopulations in high endothelial venules and lymphatic capillaries of bronchus-associated lymphoid tissue (BALT) in the rat. American Journal of Anatomy 184(2): 139-146, 1989

Mucosa-associated lymphoid tissue lymphoma of the esophagus coexistent with bronchus-associated lymphoid tissue lymphoma of the lung. Yonsei Medical Journal 46(4): 562-566, 2005

Bronchus-associated lymphoid tissue hyperplasia of the lung. Ajr. American Journal of Roentgenology 168(4): 1044-1044, 1997

Low CD4/CD8 Ratio in Bronchus-Associated Lymphoid Tissue Is Associated with Lung Allograft Rejection. Journal of Transplantation 2012: 928081-928081, 2012